Vaccine & Infectious Diseases Excellence in Antwerp: Infectious disease prevention, control and management in a One Health policy context (VAX-IDEA).
Developing and consolidating a global infectious disease control unit with focus on parasitological diseases.
Decrypting the motivation and epidemiological determinants associated with citizen engagement in disease surveillance, prevention and control activities related to emerging infectious diseases
Developing and optimizing stochastic individual-based infectious disease simulation models by parallel multicore computing techniques.
Infection control in the management of highly pathogenic infectious diseases: consensus of the European Network of Infectious Disease
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) C
Special infectious disease risks of expatriates and long-term travelers in tropical countries. Part II: Infections other than malaria
Reciprocal antibody and complement responses of two chicken breeds to vaccine strains of Newcastle disease virus, infectious bursal disease virus and infectious bronchitis virus
NEW DISUBSTITUTED TRIAZINE DIMER COMPOUNDS USEFUL FOR PREVENTING AND/OR TREATING E.G. PARASITIC DISEASE, VIRAL DISEASE, AFRICAN TRYPANOSOMIASIS, LEISHMANIASIS, MALARIA, HIV, TUBERCULOSIS, CHOLERA, DENGUE, DIARRHEA AND MEASLES
An automated platform for multiparameter data collection on live pathogens of higher or unknown biosafety risk (CAPS-IT)
Modular high-end mass spectrometer for ultra-sensitive quantification and imaging of small organic molecules in cross-health research (MSsmall-XH)
Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples